DexCom, Inc. (DXCM), a San Diego-based medical device company with a $32.5 billion market cap, specializes in continuous ...

Usually, patients using the CGM system need three components – a sensor, which has to be replaced every week, a transmitter that has to be replaced about 2-4 times a year and the Dexcom receiver.

The G4 also offered a longer transmission range between its sensors and the receiver and a more user-friendly color LCD display than previous devices. In 2015, DexCom followed up the G4 with the G5.

Dexcom's One+ glucose monitor and a receiver for the device. Dexcom issued a recall for its One+, One, G7 and G6 CGMs because receivers for the devices may not issue audible alerts due to a ...

It sends readings every five minutes from a tiny sensor under your skin to your smartphone or a receiver via Bluetooth. With the G7, Dexcom has continued to refine the product with several ...

DexCom, Inc.'s (NASDAQ: DXCM) continuous glucose monitors (CGM) are increasingly being used by diabetics to track their blood glucose levels, and based on the company's second-quarter results, the ...

San Diego-based Dexcom G6 has been manufacturing CGM technology since its inception in 2005, and its sensors are designed to become more accurate, reliable, and convenient with each upgrade.

The G7 sensor was cleared for use by people ages 2 and older with either Type 1 or Type 2 diabetes, Dexcom announced Thursday. The stateside rollout will begin “in the coming months,” CEO ...